BDSX
Biodesix Inc
NASDAQ: BDSX · HEALTHCARE · DIAGNOSTICS & RESEARCH
$15.32
-0.97% today
Updated 2026-05-08
Market cap
$113.91M
P/E ratio
—
P/S ratio
1.29x
EPS (TTM)
$-4.75
Dividend yield
—
52W range
$3 – $20
Volume
0.1M
Biodesix Inc (BDSX) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$15.32
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$19.42
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.1B | $0.0B | $0.0B | $0.1B | $0.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -39.90%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.